Literature DB >> 15851714

Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training.

Barbara J Nicklas1, Tongjian You, Marco Pahor.   

Abstract

Persistent low-grade inflammation, as indicated by higher circulating levels of inflammatory mediators such as C-reactive protein, interleukin-6 and tumour necrosis factor-alpha, is a strong risk factor for several chronic diseases. There are data indicating that decreasing energy intake and increasing physical activity may be effective therapies for reducing overall inflammation. Evidence is strong that circulating levels of inflammatory markers are elevated with total and abdominal obesity, possibly owing to a higher secretion rate of cytokines by adipose tissue in obese people. Moreover, very-low-energy dietary weight loss reduces both circulating markers of inflammation and adipose-tissue cytokine production. Data from several large population-based cohorts show an inverse association between markers of systemic inflammation and physical activity or fitness status; small-scale intervention studies support that exercise training diminishes inflammation. Dietary weight loss plus exercise is likely more effective than weight reduction alone in reducing inflammation. To date, data from randomized, controlled trails designed to definitively test the effects of weight loss or exercise training, or both, on inflammation are limited. Future studies are required to define the amount of weight loss needed for clinically meaningful reductions of inflammation; in addition, fully powered and controlled studies are necessary to clarify the effect of exercise training on chronic, systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851714      PMCID: PMC557073          DOI: 10.1503/cmaj.1040769

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  128 in total

1.  Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure.

Authors:  A I Larsen; P Aukrust; T Aarsland; K Dickstein
Journal:  Am J Cardiol       Date:  2001-10-01       Impact factor: 2.778

2.  Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.

Authors:  Marco Pahor; Lonneke V Franse; Steven R Deitcher; William C Cushman; Karen C Johnson; Ronald I Shorr; Kandice Kottke-Marchant; Russell P Tracy; Grant W Somes; William B Applegate
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program.

Authors:  S Gallistl; K M Sudi; R Aigner; M Borkenstein
Journal:  Int J Obes Relat Metab Disord       Date:  2001-11

4.  Weight loss reduces C-reactive protein levels in obese postmenopausal women.

Authors:  André Tchernof; Amy Nolan; Cynthia K Sites; Philip A Ades; Eric T Poehlman
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

5.  Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.

Authors:  N S Rost; P A Wolf; C S Kase; M Kelly-Hayes; H Silbershatz; J M Massaro; R B D'Agostino; C Franzblau; P W Wilson
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

6.  Hyperglycemia-induced production of acute phase reactants in adipose tissue.

Authors:  Y Lin; M W Rajala; J P Berger; D E Moller; N Barzilai; P E Scherer
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

7.  C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women.

Authors:  N Pannacciulli; F P Cantatore; A Minenna; M Bellacicco; R Giorgino; G De Pergola
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

8.  The relation of body fat mass and distribution to markers of chronic inflammation.

Authors:  A Festa; R D'Agostino; K Williams; A J Karter; E J Mayer-Davis; R P Tracy; S M Haffner
Journal:  Int J Obes Relat Metab Disord       Date:  2001-10

9.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

10.  Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal.

Authors:  Cynthia K Sites; Michael J Toth; Mary Cushman; Georgia D L'Hommedieu; André Tchernof; Russell P Tracy; Eric T Poehlman
Journal:  Fertil Steril       Date:  2002-01       Impact factor: 7.329

View more
  70 in total

Review 1.  Depression as a disease of modernity: explanations for increasing prevalence.

Authors:  Brandon H Hidaka
Journal:  J Affect Disord       Date:  2012-01-12       Impact factor: 4.839

2.  Exercise training, inflammation and heart failure: working out to cool down.

Authors:  Eduard Guasch; Begoña Benito; Stanley Nattel
Journal:  J Physiol       Date:  2010-07-15       Impact factor: 5.182

3.  Other advantages to aerobic exercise.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Gian Cesare Guidi
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

Review 4.  Health benefits of physical activity: the evidence.

Authors:  Darren E R Warburton; Crystal Whitney Nicol; Shannon S D Bredin
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

5.  Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women.

Authors:  Nadia Lakhdar; Myriam Denguezli; Monia Zaouali; Abdelkrim Zbidi; Zouhair Tabka; Anissa Bouassida
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

6.  Lifestyle modifications and the resolution of obstructive sleep apnea syndrome: a case report.

Authors:  Thaddeus R Gala; David R Seaman
Journal:  J Chiropr Med       Date:  2011-04-05

Review 7.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

Review 8.  Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms.

Authors:  Tongjian You; Nicole C Arsenis; Beth L Disanzo; Michael J Lamonte
Journal:  Sports Med       Date:  2013-04       Impact factor: 11.136

9.  The inverse association between cardiorespiratory fitness and C-reactive protein is mediated by autonomic function: a possible role of the cholinergic antiinflammatory pathway.

Authors:  Sae Young Jae; Kevin S Heffernan; Eun Sun Yoon; Moon-Kyu Lee; Bo Fernhall; Won Hah Park
Journal:  Mol Med       Date:  2009-06-06       Impact factor: 6.354

10.  A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study.

Authors:  L Maria Belalcazar; David M Reboussin; Steven M Haffner; Ron C Hoogeveen; Andrea M Kriska; Dawn C Schwenke; Russell P Tracy; F Xavier Pi-Sunyer; Christie M Ballantyne
Journal:  Diabetes Care       Date:  2010-08-03       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.